J. Vallejo

发表

Mapping structural brain alterations in obsessive-compulsive disorder.

J. Pujol, C. Soriano-Mas, J. Deus, 2004, Archives of general psychiatry.

Relation of Neurological Soft Signs to Nonverbal Memory Performance in Obsessive-Compulsive Disorder

José Manuel Menchón, Cary R. Savage, Pino Alonso, 2003, Journal of clinical and experimental neuropsychology.

Anatomical Variability of the Anterior Cingulate Gyrus and Basic Dimensions of Human Personality

Tomás Paus, Jesús Pujol, Narcís Cardoner, 2002, NeuroImage.

Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type

M. Gratacós, L. Armengol, X. Estivill, 2003, Molecular Psychiatry.

Early‐ and late‐onset depression in the older: no differences found within the melancholic subtype

J. Menchón, J. Vallejo, M. Urretavizcaya, 2011, International journal of geriatric psychiatry.

Effects of Duloxetine Treatment on Brain Response to Painful Stimulation in Major Depressive Disorder

B. Harrison, J. Pujol, C. Soriano-Mas, 2010, Neuropsychopharmacology.

Reduced design fluency in subclinical obsessive-compulsive subjects.

C. Junqué, J. Vallejo, M. Barrios, 1999, The Journal of neuropsychiatry and clinical neurosciences.

Seasonal variability in blood platelet 3H-imipramine binding in healthy controls: Age and gender effects

J. Menchón, J. Vallejo, T. Cortadellas, 1996, Biological Psychiatry.

Eating disorder in a patient with phenotypical features of Lujan–Fryns syndrome

P. Alonso, J. Menchón, J. Vallejo, 2006, Clinical dysmorphology.

Enlargement of brain cerebrospinal fluid spaces as a predictor of poor clinical outcome in melancholia.

J. Pujol, J. Deus, N. Cardoner, 2003, The Journal of clinical psychiatry.

Growth hormone response to growth hormone releasing hormone in non-delusional and delusional depression and healthy controls

J. Menchón, J. Vallejo, M. Navarro, 1996, Psychological Medicine.

Clomipramine versus Phenelzine in Obsessive–Compulsive Disorder

A. Bulbena, J. Menchón, J. Vallejo, 1992, British Journal of Psychiatry.

Dexamethasone suppression test and primary obsessional compulsive disorder.

A. Bulbena, J. Vallejo, M. J. Martínez-Osaba, 1988, Comprehensive psychiatry.

Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims

L. San, J. Vallejo, B. Arranz, 2000, Psychiatry Research: Neuroimaging.

S-1-4 The use of antiandrogen therapy in refractory obsessive-compulsive male patients

J. Vallejo, D. Barcia, A. Tejero, 1995, European Neuropsychopharmacology.

Hormonal differences between psychotic and non-psychotic melancholic depression.

G. Parker, J. Menchón, J. Vallejo, 2007, Journal of affective disorders.

Onset of antidepressant action: a pharmacological question?

K. Gibert, J. Vallejo, J. Cobo, 2005, Human psychopharmacology.

Treatment of refractory rapid cycling bipolar disorder with risperidone.

J. Vallejo, E. Vieta, C. Gastó, 1998, Journal of clinical psychopharmacology.

Outpatient group therapy for anorexia nervosa: A preliminary study

J. Vallejo, F. Fernández-Aranda, M. Bel, 1998, Eating and weight disorders : EWD.

Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.

P. Alonso, J. Menchón, J. Vallejo, 2001, The Journal of clinical psychiatry.

Obsessive‐compulsive and eating disorders: Comparison of clinical and personality features

P. Alonso, J. Menchón, J. Vallejo, 2007, Psychiatry and clinical neurosciences.

Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.

J. Menchón, J. Vallejo, B. Arranz, 1997, Journal of affective disorders.

Changes in platelet 3-H-imipramine binding: Influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used

J. Menchón, J. Vallejo, M. Navarro, 1995, Biological Psychiatry.

Double-Blind Study of Imipramine versus Phenelzine in Melancholias and Dysthymic Disorders

J. Vallejo, R. Catalán, M. Salamero, 1987, British Journal of Psychiatry.

Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients.

J. Menchón, J. Vallejo, B. Arranz, 1999, Journal of affective disorders.

Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains

J. Menchón, J. Vallejo, B. Arranz, 1998, Psychiatry Research: Neuroimaging.

H paroxetine binding sites in suicide brains

J. Menchón, J. Vallejo, B. Arranz, 1998 .

Verbal and nonverbal memory processing in patients with obsessive-compulsive disorder: its relationship to clinical variables.

P. Alonso, J. Menchón, J. Vallejo, 2008, Neuropsychology.

Marital status and eating disorders: an analysis of its relevance.

J. Vallejo, F. Fernández-Aranda, S. Jiménez-Murcia, 2002, Journal of psychosomatic research.

High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains

J. Menchón, J. Vallejo, B. Arranz, 2005, Journal of Neural Transmission.

Augmentation of Electroconvulsive Therapy Seizures With Sleep Deprivation

J. Vallejo, E. Rojo, Ester Gilabert, 2004, The journal of ECT.

[Psychoeducative ambulatory group in bulimia nervosa. Evaluation of a short-term approach].

P. Alonso, J. Vallejo, I. Sánchez, 1998, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.

Identifying brain imaging correlates of clinical response to repetitive transcranial magnetic stimulation (rTMS) in major depression

J. Pujol, C. Soriano-Mas, J. Deus, 2013, Brain Stimulation.

Brain structural correlates of depressive comorbidity in obsessive–compulsive disorder

Jesús Pujol, Ben J. Harrison, Joan Deus, 2007, NeuroImage.

Auditory event-related potentials in 50 melancholic patients: increased N100, N200 and P300 latencies and diminished P300 amplitude.

N. Cardoner, J. Menchón, J. Vallejo, 2003, Journal of affective disorders.

Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa.

Xavier Estivill, Josep M Mercader, Julio Vallejo, 2008, Journal of psychiatric research.

Platelet serotonin-binding and dexamethasone suppression test in melancholia and dysthymia

J. Vallejo, R. Catalán, C. Gastó, 1994, European Psychiatry.

Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder

M. Gratacós, X. Estivill, G. Escaramís, 2010, Neuropsychopharmacology.

Anxiety disorders in the joint hypermobility syndrome

J. Vallejo, A. Bulbena, R. Martin-Santos, 1993, Psychiatry Research.

Genetic susceptibility to obsessive‐compulsive hoarding: the contribution of neurotrophic tyrosine kinase receptor type 3 gene 1

M. Gratacós, X. Estivill, G. Escaramís, 2008, Genes, brain, and behavior.

Self‐injurious behaviour in people with eating disorders

J. Vallejo, F. Fernández-Aranda, R. Solano, 2005 .

Female reproductive cycle and obsessive-compulsive disorder.

P. Alonso, J. Menchón, J. Vallejo, 2005, The Journal of clinical psychiatry.

Differential features between bipolar I and bipolar II disorder.

J. Vallejo, E. Vieta, C. Gastó, 1997, Comprehensive psychiatry.

Contribution of NTRK2 to the genetic susceptibility to anorexia nervosa, Harm avoidance and minimum body mass index

M. Gratacós, X. Estivill, M. Ribasés, 2005, Molecular Psychiatry.

A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders

M. Gratacós, X. Estivill, M. Bayés, 2008, The Pharmacogenomics Journal.

Neuropsychological performance in medicated vs. unmedicated patients with obsessive–compulsive disorder

P. Alonso, J. Menchón, J. Vallejo, 2002, Psychiatry Research.

Rate and significance of hypomanic switches in unipolar melancholic depression

J. Vallejo, E. Vieta, R. Catalán, 1993, European Psychiatry.

Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators.

A. Bulbena, J. Menchón, J. Vallejo, 1991, Journal of affective disorders.

Prediction of depressive relapse in remitted bipolar patients using corticotrophin‐releasing hormone challenge test

J. Vallejo, E. Vieta, C. Gastó, 1997, Acta psychiatrica Scandinavica.

Cortisol-binding globulin levels in bipolar disorder

J. Vallejo, E. Vieta, L. Pintor, 1997, European Psychiatry.

Neuropsychological functioning in a subclinical obsessive-compulsive sample

C. Junqué, J. Vallejo, M. Barrios, 1999, Biological Psychiatry.

Impulse control disorders in eating disorders: clinical and therapeutic implications.

Susana Jiménez-Murcia, Roser Granero, Julio Vallejo, 2006, Comprehensive psychiatry.

Personality and psychopathological traits of males with an eating disorder

D. Collier, J. Vallejo, F. Fernández-Aranda, 2004 .

Does Additional Body Therapy Improve the Treatment of Anorexia Nervosa? A Comparison of Two Approaches

R. Meermann, J. Vallejo, J. Siegfried, 1995 .

Blood Levels of Brain-Derived Neurotrophic Factor Correlate with Several Psychopathological Symptoms in Anorexia Nervosa Patients

J. González, M. Gratacós, X. Estivill, 2008, Neuropsychobiology.

Suicide in patients treated for obsessive-compulsive disorder: a prospective follow-up study.

P. Alonso, J. Menchón, J. Vallejo, 2010, Journal of affective disorders.

Clinical implications of insight assessment in obsessive-compulsive disorder.

N. Cardoner, P. Alonso, J. Menchón, 2008, Comprehensive psychiatry.

Comorbidity of Pathological Gambling: clinical variables, personality and response to treatment

J. Menchón, J. Vallejo, F. Fernández-Aranda, 2009 .

xtensive Genotyping of the BDNF and NTRK 2 enes Define Protective Haplotypes Against bsessive-Compulsive Disorder

J. González, M. Gratacós, X. Estivill, 2008 .

Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder

M. Gratacós, X. Estivill, G. Escaramís, 2011, Psychoneuroendocrinology.

A case-control study of sex differences in strategic processing and episodic memory in obsessive-compulsive disorder.

P. Alonso, J. Menchón, J. Vallejo, 2010, Comprehensive psychiatry.

Identifying patients with obsessive–compulsive disorder using whole-brain anatomy

Christian Gaser, Jesús Pujol, Ben J. Harrison, 2007, NeuroImage.

Hemispheric functional imbalance in a sub-clinical obsessive-compulsive sample assessed by the Continuous Performance Test, Identical Pairs version

C. Junqué, J. Vallejo, M. Barrios, 1997, Psychiatry Research.

Comorbidity in pathological gambling: clinical variables, personality and treatment response.

J. Menchón, J. Vallejo, F. Fernández-Aranda, 2009, Revista de psiquiatria y salud mental.

Individual versus group cognitive–behavioral treatment for obsessive–compulsive disorder: a controlled pilot study

J. Menchón, J. Vallejo, S. Jiménez-Murcia, 2008, Psychotherapy research : journal of the Society for Psychotherapy Research.

The Strategy of Combining Antidepressants in the Treatment of Major Depression: Clinical Experience in Spanish Outpatients

K. Gibert, J. Vallejo, A. Bulbena, 2011, Depression research and treatment.

JOINT HYPERMOBILITY SYNDROME AND ANXIETY DISORDERS

J. Vallejo, A. Bulbena, J. Duró, 1988, The Lancet.

Impairment of incidental memory for frequency in patients with obsessive–compulsive disorder

C. Junqué, J. Vallejo, M. A. Jurado, 2001, Psychiatry Research.

Oral contraceptive pill use and changes in obsessive-compulsive symptoms.

P. Alonso, J. Menchón, J. Vallejo, 2006, Journal of psychosomatic research.

Comparison of personality risk factors in bulimia nervosa and pathological gambling.

Isabel Krug, Susana Jiménez-Murcia, Roser Granero, 2007, Comprehensive psychiatry.

Perceived parental rearing style in obsessive–compulsive disorder: relation to symptom dimensions

P. Alonso, J. Menchón, J. Vallejo, 2004, Psychiatry Research.

THE CUT-OFF POINT IN SUB-CLINICAL OBSESSIVE-COMPULSIVE RESEARCH

J. Vallejo, D. Mataix-Cols, M. Sánchez-Turet, 2000, Behavioural and Cognitive Psychotherapy.

Ziprasidone: from pharmacology to the clinical practice. One year of experience.

J. Vallejo, T. Díez, J. Saiz-ruiz, 2005, Actas espanolas de psiquiatria.

Cognitive–behavioral group treatment for pathological gambling: analysis of effectiveness and predictors of therapy outcome

J. Vallejo, S. Jiménez-Murcia, E. Álvarez-Moya, 2007 .

High sensitivity to punishment and low impulsivity in obsessive-compulsive patients with hoarding symptoms

M. Fullana, P. Alonso, J. Menchón, 2004, Psychiatry Research.

Suicidal behavior in bipolar I and bipolar II disorder.

J. Vallejo, E. Vieta, C. Gastó, 1997, The Journal of nervous and mental disease.

Are There Sex Differences in Neuropsychological Functions Among Patients With Obsessive-Compulsive Disorder?

J. Menchón, J. Vallejo, D. Mataix-Cols, 2006, Applied neuropsychology.

Reliability, Validity, and Classification Accuracy of a Spanish Translation of a Measure of DSM-IV Diagnostic Criteria for Pathological Gambling

J. Vallejo, F. Fernández-Aranda, S. Jiménez-Murcia, 2009, Journal of Gambling Studies.

Functional magnetic resonance imaging study of frontal lobe activation during word generation in obsessive–compulsive disorder

J. Pujol, J. Deus, N. Cardoner, 1999, Biological Psychiatry.

[Neuroactivation of the Tower of Hanoi in patients with obsessive-compulsive disorder and healthy volunteers].

J. Menchón, J. Vallejo, D. Mataix-Cols, 2003, Revista espanola de medicina nuclear.

Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

J. Pujol, J. Deus, N. Cardoner, 2001, The American journal of psychiatry.

Convergent and Discriminant Validity of the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist

M. Fullana, P. Alonso, J. Menchón, 2004, Psychotherapy and Psychosomatics.

A SPANISH VERSION OF THE PADUA INVENTORY: FACTOR STRUCTURE AND PSYCHOMETRIC PROPERTIES

J. Vallejo, D. Mataix-Cols, M. Sánchez-Turet, 2002, Behavioural and Cognitive Psychotherapy.

Personality characteristics in obsessive-compulsive disorder and individuals with subclinical obsessive-compulsive problems.

Pino Alonso, Miquel Angel Fullana, David Mataix-Cols, 2004, The British journal of clinical psychology.

Residual symptoms and comorbidity in panic disorder

J. Vallejo, T. Guerrero, A. Corominas, 2002, European Psychiatry.

Gender differences in obsessive–compulsive symptom dimensions

J. Leckman, P. Alonso, J. Menchón, 2008, Depression and anxiety.

Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patients.

J. Menchón, J. Vallejo, B. Arranz, 2002, Journal of affective disorders.

Stressful life events at onset of obsessive–compulsive disorder are associated with a distinct clinical pattern

P. Alonso, J. Menchón, J. Vallejo, 2011, Depression and anxiety.

Dynamic assessment of the right lateral frontal cortex response to painful stimulation

Jesús Pujol, Ben J. Harrison, Joan Deus, 2010, NeuroImage.

Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT2A receptors in Brodmann areas and brain hemispheres

L. San, J. Vallejo, B. Arranz, 2002, Psychiatry Research.

Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT receptors in Brodmann areas and brain

L. San, J. Vallejo, B. Arranz, 2002 .

CSF Spaces of the Sylvian Fissure Region in Severe Melancholic Depression

Jesús Pujol, Joan Deus, Julio Vallejo, 2002, NeuroImage.

Obsessive-Compulsive Disorder (OCD) Patients are Impaired in Remembering Temporal Order and in Judging Their Own Performance

J. Grafman, C. Junqué, J. Vallejo, 2002, Journal of clinical and experimental neuropsychology.

Clomipramine versus Phenelzine in Obsessiveâ€ ” Compulsive Disorder A Controlled Clinical Trial

A. Bulbena, J. Vallejo, J. Olivares, 2006 .

Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain

J. Vallejo, B. Arranz, M. Navarro, 2005, Journal of Neural Transmission.

Personality dimensions in obsessive–compulsive disorder: Relation to clinical variables

Jesús Pujol, José M. Menchón, Narcís Cardoner, 2008, Psychiatry Research.

Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.

J. Vallejo, J. Buigues, 1987, The Journal of clinical psychiatry.

A controlled clinical trial Clomipramine versus phenelzine in obsessive-compulsive disorder.

A. Bulbena, J. Menchón, J. Vallejo, 2011 .

P0367 - Cognitive-behavioral group treatment for pathological gambling: Analysis of effectiveness and predictors of therapy outcome

S. Jimenez-Murcia, J. Vallejo, S. Jiménez-Murcia, 2008, European Psychiatry.

P0086 - Reliability, validity, and classification accuracy of a Spanish translation of a measure of DSM-IV diagnostic criteria for pathological gambling

J. Vallejo, F. Fernández-Aranda, S. Jiménez-Murcia, 2008, European Psychiatry.

A case-control study of sex differences in strategic processing and episodic memory in obsessive-compulsive disorder.

P. Alonso, J. Menchón, J. Vallejo, 2010, Comprehensive psychiatry.